Haoxi Health Technology Limited — Form 6-K Summary
Business context and reporting period
This Form 6-K, dated January 30, 2024, covers the month of January 2024. The filing reports the pricing and closing of the company’s initial public offering, rather than operating results for a reporting period.
IPO and key financial metrics
- The company closed its IPO on January 30, 2024, issuing 2,400,000 Class A ordinary shares.
- The offering price was $4.00 per share, resulting in gross offering proceeds of $9.6 million before underwriting discounts, commissions, and other offering expenses.
- The shares have a par value of $0.0001 per share.
- The shares began trading on the Nasdaq Capital Market under the ticker symbol HAO on January 26, 2024.
- The filing does not provide updated revenue, profit, cash flow, margins, debt, liquidity, or balance-sheet figures.
Material changes and transaction details
- The SEC declared the company’s Form F-1 registration statement effective on January 25, 2024.
- The IPO was conducted on a firm-commitment basis under an underwriting agreement dated January 25, 2024.
- EF Hutton LLC served as the sole book-running manager.
- The filing reflects the company’s transition to a publicly traded issuer but does not quantify the impact of the IPO on cash, capitalization, or ownership.
Guidance, outlook, risks, and unusual items
The filing provides no financial guidance or operating outlook. It includes standard securities-law language stating that the securities may not be offered or sold where doing so would violate applicable registration or qualification requirements. No specific contingencies, unusual expenses, or risk developments are described in the filing text.
Investor verification points
- Verify net IPO proceeds after underwriting discounts, commissions, and offering expenses.
- Review the effective Form F-1 for dilution, capitalization, use of proceeds, risk factors, and financial statements.
- Confirm post-IPO cash and liquidity balances and any outstanding debt.
- Assess the company’s operating performance separately, as this Form 6-K does not report current revenue or profitability.
- Review Exhibits 99.1 and 99.2, which contain the IPO pricing and closing press releases.